ONTOLOGY REPORT - ANNOTATIONS
| Term: | N-nitrosodimethylamine |
|
| Accession: | CHEBI:35807
|
browse the term
|
| Definition: | A nitrosamine that has formula C2H6N2O. |
| Synonyms: | exact_synonym: | N-methyl-N-nitrosomethanamine |
| | related_synonym: | 1,1-Dimethyl-2-oxohydrazine; C2H6N2O; CN(C)N=O; DMN; Dimethylnitrosamine; Dimethylnitrosoamine; InChI=1S/C2H6N2O/c1-4(2)3-5/h1-2H3; InChIKey=UMFJAHHVKNCGLG-UHFFFAOYSA-N; N,N-Dimethylnitrosamine |
| | alt_id: | CHEBI:21778; CHEBI:34874 |
| | xref_casrn: | 62-75-9 |
| | xref: | ChEMBL:290955 "ChEMBL COMPOUND"; ChemIDplus:62-75-9 "CAS Registry Number"; KEGG COMPOUND:62-75-9 "CAS Registry Number"; KEGG COMPOUND:C14704 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D004128 |
| | xref: | NIST Chemistry WebBook:62-75-9 "CAS Registry Number" |
|
|
N-nitrosodimethylamine
|
| G |
A2m |
alpha-2-macroglobulin |
|
decreases expression |
ISO |
4 |
158,103,711 |
158,153,423 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
decreases expression |
EXP |
1 |
96,622,574 |
96,703,723 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
decreases expression |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Acp2 |
acid phosphatase 2, lysosomal |
|
decreases expression |
ISO |
3 |
75,559,522 |
75,568,415 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
decreases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
decreases expression |
EXP |
2 |
235,952,313 |
235,970,671 |
RGD:6480464 |
CTD |
| G |
Adh6a |
alcohol dehydrogenase 6A (class V) |
|
decreases expression |
ISO |
2 |
235,842,525 |
235,850,491 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Aif1 |
allograft inflammatory factor 1 |
|
increases expression |
EXP |
20 |
3,714,428 |
3,716,327 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
increases expression |
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
decreases expression |
ISO |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
|
decreases expression |
ISO |
1 |
245,685,979 |
245,718,198 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Amacr |
alpha-methylacyl-CoA racemase |
|
decreases expression |
EXP |
2 |
60,332,292 |
60,344,326 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
increases expression |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
increases expression |
EXP |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression |
EXP |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
increases expression |
ISO |
5 |
58,501,642 |
58,507,159 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
increases expression |
EXP |
5 |
58,433,731 |
58,447,853 |
RGD:6480464 |
CTD |
| G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
|
increases expression |
EXP |
12 |
9,796,269 |
9,803,639 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression |
ISO |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
decreases expression |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp5g1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
|
decreases expression |
EXP |
10 |
84,788,650 |
84,791,230 |
RGD:6480464 |
CTD |
| G |
Atp6v1d |
ATPase, H+ transporting, lysosomal V1 subunit D |
|
increases expression |
EXP |
6 |
101,479,417 |
101,494,826 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdh1 |
3-hydroxybutyrate dehydrogenase, type 1 |
|
decreases expression |
EXP |
11 |
71,130,561 |
71,165,695 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
decreases expression |
EXP |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
|
increases expression |
ISO |
1 |
82,528,943 |
82,546,606 |
RGD:6480464 |
CTD |
| G |
Bmp3 |
bone morphogenetic protein 3 |
|
increases expression |
EXP |
14 |
12,065,635 |
12,090,295 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Bub3 |
budding uninhibited by benzimidazoles 3 homolog (S. cerevisiae) |
|
increases expression |
ISO |
1 |
191,128,891 |
191,139,401 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
increases expression |
EXP |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
increases expression |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
EXP |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
EXP |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl22 |
chemokine (C-C motif) ligand 22 |
|
increases expression |
EXP |
19 |
10,697,324 |
10,704,129 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
EXP |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
EXP |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
increases expression |
EXP |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
affects expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cct3 |
chaperonin containing Tcp1, subunit 3 (gamma) |
|
increases expression |
EXP |
2 |
180,381,044 |
180,434,152 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
EXP |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
multiple interactions |
EXP |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
increases expression |
EXP |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
increases expression |
EXP |
18 |
56,756,511 |
56,765,711 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
increases expression |
EXP |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
decreases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk16 |
cyclin-dependent kinase 16 |
|
increases expression |
EXP |
X |
12,910,972 |
12,916,939 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
EXP |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
decreases expression |
EXP |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Ces1d |
carboxylesterase 1D |
|
decreases expression |
EXP |
19 |
14,928,539 |
14,967,082 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
increases expression |
EXP |
19 |
34,910,981 |
34,925,547 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
increases expression |
EXP |
19 |
34,910,981 |
34,925,547 |
RGD:6480464 |
CTD |
| G |
Ces3a |
carboxylesterase 3a |
|
decreases expression |
EXP |
19 |
34,929,247 |
34,937,267 |
RGD:6480464 |
CTD |
| G |
Cetn2 |
centrin, EF-hand protein, 2 |
|
decreases expression |
ISO |
X |
158,917,650 |
158,923,210 |
RGD:6480464 |
CTD |
| G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
|
increases expression |
EXP |
6 |
25,414,812 |
25,426,818 |
RGD:6480464 |
CTD |
| G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
|
increases expression |
EXP |
6 |
25,414,812 |
25,426,818 |
RGD:6480464 |
CTD |
| G |
Cgrrf1 |
cell growth regulator with ring finger domain 1 |
|
increases expression |
EXP |
15 |
22,683,387 |
22,703,833 |
RGD:6480464 |
CTD |
| G |
Cideb |
cell death-inducing DFFA-like effector b |
|
decreases expression |
ISO |
15 |
33,916,472 |
33,920,872 |
RGD:6480464 |
CTD |
| G |
Cidec |
cell death-inducing DFFA-like effector c |
|
increases expression |
ISO |
4 |
149,307,986 |
149,321,303 |
RGD:6480464 |
CTD |
| G |
Clptm1 |
cleft lip and palate associated transmembrane protein 1 |
|
decreases expression |
ISO |
1 |
78,938,917 |
78,970,676 |
RGD:6480464 |
CTD |
| G |
Cml1 |
camello-like 1 |
|
decreases expression |
EXP |
4 |
120,059,311 |
120,065,996 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
affects expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Cr1l |
complement component (3b/4b) receptor 1-like |
|
increases expression |
EXP |
13 |
111,010,296 |
111,057,427 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
decreases expression |
EXP |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Cry1 |
cryptochrome 1 (photolyase-like) |
|
increases expression |
ISO |
7 |
20,643,879 |
20,709,216 |
RGD:6480464 |
CTD |
| G |
Cryaa |
crystallin, alpha A |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cryaa |
crystallin, alpha A |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Csad |
cysteine sulfinic acid decarboxylase |
|
decreases expression |
EXP |
7 |
140,917,995 |
140,944,405 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
increases expression |
EXP |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Cstb |
cystatin B (stefin B) |
|
increases expression |
EXP |
20 |
10,576,664 |
10,578,706 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
EXP |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
increases expression |
ISO |
8 |
94,971,689 |
94,990,434 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
increases expression |
EXP |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
decreases expression |
ISO |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
affects expression |
ISO |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cyb5b |
cytochrome b5 type B (outer mitochondrial membrane) |
|
multiple interactions |
ISO |
19 |
37,016,959 |
37,050,722 |
RGD:6480464 |
CTD |
| G |
Cyb5r3 |
cytochrome b5 reductase 3 |
|
decreases expression |
EXP |
7 |
121,187,821 |
121,205,382 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases hydroxylation |
EXP |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases methylation |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases methylation |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases methylation |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
decreases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
increases expression |
EXP |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
increases expression |
EXP |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
increases expression |
EXP |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddx21b |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 21b |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dfna5 |
deafness, autosomal dominant 5 (human) |
|
increases expression |
ISO |
4 |
78,431,841 |
78,492,217 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
decreases expression |
ISO |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
decreases expression |
EXP |
5 |
128,385,702 |
128,404,015 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
decreases expression |
EXP |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp13 |
dual specificity phosphatase 13 |
|
increases expression |
ISO |
15 |
2,614,864 |
2,630,230 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
decreases expression |
EXP |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dut |
deoxyuridine triphosphatase |
|
increases expression |
EXP |
3 |
112,551,434 |
112,562,434 |
RGD:6480464 |
CTD |
| G |
Ebp |
emopamil binding protein (sterol isomerase) |
|
decreases expression |
ISO |
X |
26,331,199 |
26,337,542 |
RGD:6480464 |
CTD |
| G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
|
increases expression |
EXP |
1 |
211,640,954 |
211,651,560 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
increases expression |
EXP |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
increases expression |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eno2 |
enolase 2, gamma, neuronal |
|
increases expression |
ISO |
4 |
160,891,003 |
160,897,723 |
RGD:6480464 |
CTD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
increases expression |
ISO |
1 |
21,223,678 |
21,287,411 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
decreases expression |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ets2 |
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
increases expression |
ISO |
11 |
36,014,047 |
36,030,833 |
RGD:6480464 |
CTD |
| G |
F10 |
coagulation factor X |
|
decreases expression |
ISO |
16 |
81,327,237 |
81,346,544 |
RGD:6480464 |
CTD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
decreases expression |
ISO |
13 |
79,934,956 |
79,997,285 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
decreases expression |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp7 |
fatty acid binding protein 7, brain |
|
decreases expression |
EXP |
20 |
36,812,518 |
36,816,050 |
RGD:6480464 |
CTD |
| G |
Fah |
fumarylacetoacetate hydrolase |
|
increases expression |
ISO |
1 |
140,851,975 |
140,876,187 |
RGD:6480464 |
CTD |
| G |
Fam162a |
family with sequence similarity 162, member A |
|
increases expression |
EXP |
11 |
66,518,103 |
66,546,302 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
decreases expression |
ISO |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases expression |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fez2 |
fasciculation and elongation protein zeta 2 (zygin II) |
|
increases expression |
ISO |
6 |
1,145,261 |
1,184,406 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
increases expression |
EXP |
17 |
15,512,144 |
15,527,348 |
RGD:6480464 |
CTD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
increases expression |
EXP |
4 |
165,448,027 |
165,456,481 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
decreases expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Furin |
furin (paired basic amino acid cleaving enzyme) |
|
decreases expression |
ISO |
1 |
136,209,969 |
136,222,057 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
increases expression |
EXP |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
increases expression |
EXP |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
decreases expression |
EXP |
10 |
89,273,628 |
89,276,192 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
decreases expression |
EXP |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
|
increases expression |
ISO |
8 |
74,470,610 |
74,474,086 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
EXP |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
EXP |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Ggcx |
gamma-glutamyl carboxylase |
|
decreases expression |
ISO |
4 |
105,719,323 |
105,735,037 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Gip |
gastric inhibitory polypeptide |
|
increases expression |
EXP |
10 |
84,732,705 |
84,740,801 |
RGD:6480464 |
CTD |
| G |
Gla |
galactosidase, alpha |
|
increases expression |
ISO |
X |
122,044,703 |
122,056,327 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin (thioltransferase) |
|
increases expression |
ISO |
2 |
2,888,605 |
2,899,216 |
RGD:6480464 |
CTD |
| G |
Gls2 |
glutaminase 2 (liver, mitochondrial) |
|
decreases expression |
EXP |
7 |
1,484,397 |
1,495,283 |
RGD:6480464 |
CTD |
| G |
Gnmt |
glycine N-methyltransferase |
|
decreases expression |
EXP |
9 |
10,127,092 |
10,130,444 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases expression |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
decreases expression |
ISO |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases activity |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases expression |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
increases expression |
ISO |
14 |
92,814,797 |
92,911,442 |
RGD:6480464 |
CTD |
| G |
Grpel1 |
GrpE-like 1, mitochondrial |
|
increases expression |
EXP |
14 |
79,873,191 |
79,878,998 |
RGD:6480464 |
CTD |
| G |
Grpel1 |
GrpE-like 1, mitochondrial |
|
increases expression |
EXP |
14 |
79,873,191 |
79,878,998 |
RGD:6480464 |
CTD |
| G |
Gsn |
gelsolin |
|
decreases expression |
ISO |
3 |
14,360,245 |
14,386,313 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
EXP |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
increases expression |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gulo |
gulonolactone (L-) oxidase |
|
decreases expression |
EXP |
15 |
45,410,685 |
45,434,014 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases expression |
EXP |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afz |
H2A histone family, member Z |
|
increases expression |
EXP |
2 |
235,353,027 |
235,355,136 |
RGD:6480464 |
CTD |
| G |
Hao2 |
hydroxyacid oxidase 2 (long chain) |
|
decreases expression |
EXP |
2 |
193,532,833 |
193,557,229 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
increases expression |
EXP |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
affects expression |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
increases expression |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgfac |
HGF activator |
|
decreases expression |
EXP |
14 |
81,348,282 |
81,354,836 |
RGD:6480464 |
CTD |
| G |
Hmga1 |
high mobility group AT-hook 1 |
|
increases expression |
ISO |
20 |
5,769,052 |
5,772,269 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
increases expression |
EXP |
16 |
36,131,304 |
36,133,878 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
decreases expression |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
decreases expression |
ISO |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hp |
haptoglobin |
|
decreases expression |
EXP |
19 |
39,443,016 |
39,447,566 |
RGD:6480464 |
CTD |
| G |
Hpcal1 |
hippocalcin-like 1 |
|
increases expression |
ISO |
6 |
41,458,062 |
41,576,771 |
RGD:6480464 |
CTD |
| G |
Hpd |
4-hydroxyphenylpyruvate dioxygenase |
|
increases expression |
ISO |
12 |
34,548,320 |
34,558,371 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
decreases expression |
ISO |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
decreases expression |
EXP |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
|
increases expression |
EXP |
7 |
1,118,183 |
1,137,670 |
RGD:6480464 |
CTD |
| G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
|
decreases expression |
ISO |
13 |
85,776,077 |
85,792,977 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
increases expression |
EXP |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
EXP |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
EXP |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
increases expression |
EXP |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Ide |
insulin degrading enzyme |
|
increases expression |
EXP |
1 |
241,547,869 |
241,646,052 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
increases expression |
ISO |
19 |
25,159,276 |
25,160,800 |
RGD:6480464 |
CTD |
| G |
Ifitm2 |
interferon induced transmembrane protein 2 |
|
increases expression |
ISO |
1 |
201,134,357 |
201,135,537 |
RGD:6480464 |
CTD |
| G |
Ifnb1 |
interferon beta 1, fibroblast |
|
increases expression |
ISO |
5 |
107,837,628 |
107,838,182 |
RGD:6480464 |
CTD |
| G |
Ifnb1 |
interferon beta 1, fibroblast |
|
multiple interactions |
ISO |
5 |
107,837,628 |
107,838,182 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
increases expression |
EXP |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
decreases expression |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
decreases expression |
EXP |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
increases expression |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il17rb |
interleukin 17 receptor B |
|
decreases expression |
ISO |
16 |
5,335,806 |
5,349,160 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
affects expression |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
affects expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
increases expression |
ISO |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
multiple interactions |
ISO |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
decreases expression |
EXP |
7 |
67,308,713 |
67,310,138 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
increases expression |
EXP |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
increases expression |
EXP |
15 |
83,103,177 |
83,118,363 |
RGD:6480464 |
CTD |
| G |
Klf6 |
Kruppel-like factor 6 |
|
increases expression |
ISO |
17 |
75,578,498 |
75,585,072 |
RGD:6480464 |
CTD |
| G |
Kpna4 |
karyopherin alpha 4 (importin alpha 3) |
|
increases expression |
ISO |
2 |
159,073,108 |
159,128,180 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
affects localization |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
increases expression |
EXP |
3 |
149,016,605 |
149,043,530 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
EXP |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
increases expression |
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lipa |
lipase A, lysosomal acid, cholesterol esterase |
|
decreases expression |
ISO |
1 |
238,466,493 |
238,500,195 |
RGD:6480464 |
CTD |
| G |
Lss |
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
|
decreases expression |
ISO |
20 |
12,507,575 |
12,534,612 |
RGD:6480464 |
CTD |
| G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression |
ISO |
7 |
117,328,924 |
117,340,276 |
RGD:6480464 |
CTD |
| G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
|
decreases expression |
ISO |
8 |
112,111,358 |
112,113,311 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases expression |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mat1a |
methionine adenosyltransferase I, alpha |
|
decreases expression |
EXP |
16 |
17,548,582 |
17,563,989 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
increases expression |
EXP |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
decreases expression |
ISO |
6 |
91,137,262 |
91,139,751 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
EXP |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
EXP |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression |
EXP |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
EXP |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
increases expression |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
increases expression |
EXP |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
multiple interactions |
EXP |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
multiple interactions |
EXP |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases activity |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases activity |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases activity |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mrpl49 |
mitochondrial ribosomal protein L49 |
|
decreases expression |
ISO |
1 |
208,692,089 |
208,694,868 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
decreases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mxra7 |
matrix-remodelling associated 7 |
|
increases expression |
ISO |
10 |
106,905,636 |
106,921,646 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
|
increases expression |
EXP |
7 |
50,506,870 |
50,530,177 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
decreases expression |
ISO |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
decreases expression |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Npm1 |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
increases expression |
EXP |
10 |
18,051,990 |
18,062,714 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
decreases expression |
EXP |
5 |
151,524,685 |
151,528,000 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
increases expression |
EXP |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
increases expression |
EXP |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nucb2 |
nucleobindin 2 |
|
decreases expression |
ISO |
1 |
174,605,677 |
174,642,111 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
decreases expression |
EXP |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
decreases expression |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Obp3 |
alpha-2u globulin PGCL4 |
|
decreases expression |
EXP |
5 |
78,088,876 |
78,092,317 |
RGD:6480464 |
CTD |
| G |
Obp3 |
alpha-2u globulin PGCL4 |
|
decreases expression |
EXP |
5 |
78,088,876 |
78,092,317 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
increases expression |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
increases expression |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
decreases expression |
EXP |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
decreases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
affects expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases expression |
EXP |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
multiple interactions |
EXP |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
decreases expression |
ISO |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pgc |
progastricsin (pepsinogen C) |
|
decreases expression |
ISO |
9 |
8,723,620 |
8,731,837 |
RGD:6480464 |
CTD |
| G |
Pgf |
placental growth factor |
|
decreases expression |
ISO |
6 |
109,215,540 |
109,226,122 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
increases expression |
EXP |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
increases expression |
EXP |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Phlda2 |
pleckstrin homology-like domain, family A, member 2 |
|
increases expression |
ISO |
1 |
203,878,093 |
203,879,038 |
RGD:6480464 |
CTD |
| G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
increases expression |
ISO |
5 |
166,735,274 |
166,761,189 |
RGD:6480464 |
CTD |
| G |
Pim1 |
pim-1 oncogene |
|
increases expression |
ISO |
20 |
7,817,403 |
7,821,800 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
multiple interactions |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Prkch |
protein kinase C, eta |
|
increases expression |
EXP |
6 |
96,069,354 |
96,281,790 |
RGD:6480464 |
CTD |
| G |
Prkcz |
protein kinase C, zeta |
|
increases expression |
EXP |
5 |
172,061,825 |
172,172,793 |
RGD:6480464 |
CTD |
| G |
Prom1 |
prominin 1 |
|
decreases expression |
ISO |
14 |
72,122,986 |
72,230,453 |
RGD:6480464 |
CTD |
| G |
Pros1 |
protein S (alpha) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Psma1 |
proteasome (prosome, macropain) subunit, alpha type 1 |
|
increases expression |
EXP |
1 |
172,237,763 |
172,248,782 |
RGD:6480464 |
CTD |
| G |
Psma2 |
proteasome (prosome, macropain) subunit, alpha type 2 |
|
increases expression |
EXP |
17 |
58,736,300 |
58,746,837 |
RGD:6480464 |
CTD |
| G |
Psma4 |
proteasome (prosome, macropain) subunit, alpha type 4 |
|
increases expression |
EXP |
8 |
58,508,643 |
58,516,103 |
RGD:6480464 |
CTD |
| G |
Psma5 |
proteasome (prosome, macropain) subunit, alpha type 5 |
|
increases expression |
EXP |
2 |
203,825,060 |
203,848,378 |
RGD:6480464 |
CTD |
| G |
Psma7 |
proteasome (prosome, macropain) subunit, alpha type 7 |
|
increases expression |
EXP |
3 |
169,100,807 |
169,107,149 |
RGD:6480464 |
CTD |
| G |
Psmb1 |
proteasome (prosome, macropain) subunit, beta type 1 |
|
increases expression |
EXP |
1 |
54,369,775 |
54,388,816 |
RGD:6480464 |
CTD |
| G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
|
increases expression |
EXP |
10 |
86,452,533 |
86,459,616 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
increases expression |
EXP |
2 |
189,778,476 |
189,781,169 |
RGD:6480464 |
CTD |
| G |
Psmb5 |
proteasome (prosome, macropain) subunit, beta type 5 |
|
increases expression |
EXP |
15 |
32,689,859 |
32,694,364 |
RGD:6480464 |
CTD |
| G |
Psmb9 |
proteasome (prosome, macropain) subunit, beta type, 9 |
|
increases expression |
EXP |
20 |
4,801,187 |
4,806,608 |
RGD:6480464 |
CTD |
| G |
Psmc1 |
proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
increases expression |
EXP |
6 |
124,380,976 |
124,393,338 |
RGD:6480464 |
CTD |
| G |
Psmc2 |
proteasome (prosome, macropain) 26S subunit, ATPase 2 |
|
increases expression |
EXP |
4 |
8,704,100 |
8,718,351 |
RGD:6480464 |
CTD |
| G |
Psmc4 |
proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
|
increases expression |
EXP |
1 |
83,151,149 |
83,159,464 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
increases expression |
EXP |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psmd1 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
increases expression |
EXP |
9 |
84,807,822 |
84,882,942 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase type IVA, member 1 |
|
increases expression |
EXP |
9 |
29,617,636 |
29,625,197 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
increases expression |
ISO |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
increases expression |
EXP |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
increases expression |
ISO |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Rab13 |
RAB13, member RAS oncogene family |
|
increases expression |
EXP |
2 |
182,460,998 |
182,465,393 |
RGD:6480464 |
CTD |
| G |
Rad23b |
RAD23 homolog B (S. cerevisiae) |
|
decreases expression |
ISO |
5 |
73,256,542 |
73,294,296 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
increases expression |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
increases expression |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Ralb |
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) |
|
increases expression |
EXP |
13 |
32,229,646 |
32,238,410 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases expression |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbpms |
RNA binding protein with multiple splicing |
|
increases expression |
ISO |
16 |
62,009,626 |
62,163,466 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases localization |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
RGD1310769 |
similar to HSPC288 |
|
decreases expression |
ISO |
6 |
109,934,787 |
109,945,923 |
RGD:6480464 |
CTD |
| G |
RGD1564865 |
similar to 20-alpha-hydroxysteroid dehydrogenase |
|
increases expression |
EXP |
17 |
76,868,408 |
76,903,914 |
RGD:6480464 |
CTD |
| G |
RGD1566118 |
RGD1566118 |
|
increases expression |
EXP |
20 |
3,959,539 |
3,964,122 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
decreases expression |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rheb |
Ras homolog enriched in brain |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
increases expression |
EXP |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
decreases expression |
EXP |
15 |
27,073,756 |
27,090,441 |
RGD:6480464 |
CTD |
| G |
Rph3al |
rabphilin 3A-like (without C2 domains) |
|
increases expression |
EXP |
10 |
63,179,937 |
63,265,580 |
RGD:6480464 |
CTD |
| G |
Rpl10 |
ribosomal protein L10 |
|
increases expression |
EXP |
X |
160,336,632 |
160,338,842 |
RGD:6480464 |
CTD |
| G |
Rpl10a |
ribosomal protein L10A |
|
increases expression |
EXP |
20 |
6,569,083 |
6,571,641 |
RGD:6480464 |
CTD |
| G |
Rpl13 |
ribosomal protein L13 |
|
increases expression |
EXP |
19 |
53,437,633 |
53,440,184 |
RGD:6480464 |
CTD |
| G |
Rpl15 |
ribosomal protein L15 |
|
increases expression |
EXP |
15 |
9,082,190 |
9,085,473 |
RGD:6480464 |
CTD |
| G |
Rpl17 |
ribosomal protein L17 |
|
increases expression |
EXP |
18 |
71,863,062 |
71,866,168 |
RGD:6480464 |
CTD |
| G |
Rpl17l1 |
ribosomal protein L17-like 1 |
|
increases expression |
EXP |
1 |
64,205,419 |
64,205,973 |
RGD:6480464 |
CTD |
| G |
Rpl23 |
ribosomal protein L23 |
|
increases expression |
EXP |
10 |
86,527,589 |
86,531,549 |
RGD:6480464 |
CTD |
| G |
Rpl7a |
ribosomal protein L7a |
|
increases expression |
EXP |
18 |
5,807,901 |
5,810,543 |
RGD:6480464 |
CTD |
| G |
Rpl8 |
ribosomal protein L8 |
|
increases expression |
EXP |
7 |
114,954,061 |
114,956,339 |
RGD:6480464 |
CTD |
| G |
Rps15a |
ribosomal protein S15a |
|
increases expression |
EXP |
1 |
176,321,901 |
176,327,789 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
increases expression |
EXP |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
increases expression |
EXP |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps24 |
ribosomal protein S24 |
|
increases expression |
EXP |
16 |
43,766 |
48,353 |
RGD:6480464 |
CTD |
| G |
Rps27l |
ribosomal protein S27-like |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rps27l2 |
ribosomal protein S27-like 2 |
|
increases expression |
EXP |
12 |
29,143,461 |
29,143,842 |
RGD:6480464 |
CTD |
| G |
Rps3 |
ribosomal protein S3 |
|
increases expression |
EXP |
1 |
156,811,470 |
156,816,770 |
RGD:6480464 |
CTD |
| G |
Rps4x |
ribosomal protein S4, X-linked |
|
increases expression |
EXP |
X |
34,793,683 |
34,794,576 |
RGD:6480464 |
CTD |
| G |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
|
increases expression |
EXP |
5 |
151,274,666 |
151,288,007 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
EXP |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps7 |
ribosomal protein S7 |
|
increases expression |
EXP |
6 |
46,511,961 |
46,516,825 |
RGD:6480464 |
CTD |
| G |
Rpsa |
ribosomal protein SA |
|
increases expression |
EXP |
8 |
125,100,239 |
125,104,096 |
RGD:6480464 |
CTD |
| G |
Rrm2b |
ribonucleotide reductase M2 B (TP53 inducible) |
|
increases expression |
ISO |
7 |
73,432,161 |
73,459,541 |
RGD:6480464 |
CTD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
decreases expression |
EXP |
20 |
4,730,559 |
4,736,201 |
RGD:6480464 |
CTD |
| G |
RT1-Da |
RT1 class II, locus Da |
|
increases expression |
EXP |
20 |
4,636,310 |
4,641,282 |
RGD:6480464 |
CTD |
| G |
RT1-EC2 |
RT1 class Ib, locus EC2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sar1a |
SAR1 homolog A (S. cerevisiae) |
|
decreases expression |
EXP |
20 |
29,048,217 |
29,060,624 |
RGD:6480464 |
CTD |
| G |
Scand1 |
SCAN domain-containing 1 |
|
decreases expression |
ISO |
3 |
146,710,153 |
146,711,017 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
decreases expression |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
decreases expression |
EXP |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sepw1 |
selenoprotein W, 1 |
|
increases expression |
EXP |
1 |
76,249,869 |
76,254,942 |
RGD:6480464 |
CTD |
| G |
Serpina5 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
|
decreases expression |
ISO |
6 |
128,156,901 |
128,161,334 |
RGD:6480464 |
CTD |
| G |
Serpina6 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
|
decreases expression |
ISO |
6 |
127,911,618 |
127,921,851 |
RGD:6480464 |
CTD |
| G |
Serpina7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
increases expression |
EXP |
X |
126,739,203 |
126,744,763 |
RGD:6480464 |
CTD |
| G |
Serpinb1a |
serine (or cysteine) proteinase inhibitor, clade B, member 1a |
|
decreases expression |
ISO |
17 |
37,950,875 |
37,959,284 |
RGD:6480464 |
CTD |
| G |
Serpine2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
|
increases expression |
ISO |
9 |
79,091,414 |
79,166,330 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
multiple interactions |
ISO |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
increases expression |
ISO |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Sfn |
stratifin |
|
increases expression |
ISO |
5 |
151,475,395 |
151,479,996 |
RGD:6480464 |
CTD |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
increases expression |
ISO |
2 |
181,616,581 |
181,628,144 |
RGD:6480464 |
CTD |
| G |
Sik1 |
salt-inducible kinase 1 |
|
increases expression |
ISO |
20 |
10,282,203 |
10,291,735 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
decreases expression |
EXP |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc12a6 |
solute carrier family 12, member 6 |
|
increases expression |
ISO |
3 |
98,110,547 |
98,212,242 |
RGD:6480464 |
CTD |
| G |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
|
decreases expression |
EXP |
8 |
47,363,896 |
47,369,981 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
increases phosphorylation |
EXP |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
multiple interactions |
EXP |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Spin2a |
spindlin family, member 2A |
|
decreases expression |
EXP |
X |
37,609,279 |
37,610,330 |
RGD:6480464 |
CTD |
| G |
Spint1 |
serine peptidase inhibitor, Kunitz type 1 |
|
increases expression |
EXP |
3 |
105,757,666 |
105,770,345 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
|
increases expression |
EXP |
3 |
8,956,380 |
9,021,831 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
decreases expression |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Sqrdl |
sulfide quinone reductase-like (yeast) |
|
increases expression |
ISO |
3 |
109,743,347 |
109,752,321 |
RGD:6480464 |
CTD |
| G |
Srsf1 |
serine/arginine-rich splicing factor 1 |
|
decreases expression |
ISO |
10 |
76,339,824 |
76,344,552 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
decreases expression |
EXP |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
EXP |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
decreases expression |
EXP |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
decreases expression |
EXP |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sult2a1 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
|
decreases expression |
EXP |
1 |
75,632,632 |
75,708,022 |
RGD:6480464 |
CTD |
| G |
Tap1 |
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
|
increases expression |
EXP |
20 |
4,790,363 |
4,800,730 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
decreases expression |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
multiple interactions |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
decreases expression |
EXP |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Timm10b |
translocase of inner mitochondrial membrane 10 homolog B |
|
increases expression |
EXP |
1 |
163,369,731 |
163,372,577 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
affects expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases activity |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tmed2 |
transmembrane emp24 domain trafficking protein 2 |
|
decreases expression |
ISO |
12 |
33,165,291 |
33,174,326 |
RGD:6480464 |
CTD |
| G |
Tmsb10 |
thymosin, beta 10 |
|
increases expression |
EXP |
4 |
106,286,030 |
106,287,089 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
|
increases expression |
ISO |
18 |
45,083,452 |
45,126,709 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
increases expression |
EXP |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tra2a |
transformer 2 alpha homolog (Drosophila) |
|
decreases expression |
ISO |
4 |
77,372,546 |
77,391,417 |
RGD:6480464 |
CTD |
| G |
Trib1 |
tribbles homolog 1 (Drosophila) |
|
increases expression |
ISO |
7 |
96,442,239 |
96,448,785 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
decreases expression |
EXP |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Tubb5 |
tubulin, beta 5 class I |
|
increases expression |
EXP |
20 |
3,060,224 |
3,090,776 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
increases expression |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
increases expression |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Ubd |
ubiquitin D |
|
decreases expression |
ISO |
20 |
1,475,944 |
1,477,895 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
increases expression |
ISO |
5 |
77,263,334 |
77,295,794 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases expression |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vrk2 |
vaccinia related kinase 2 |
|
increases expression |
ISO |
14 |
107,287,844 |
107,450,960 |
RGD:6480464 |
CTD |
| G |
Vtn |
vitronectin |
|
decreases expression |
ISO |
10 |
64,609,242 |
64,612,322 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
decreases expression |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
increases expression |
EXP |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
increases expression |
EXP |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
Term paths to the root
|